In conclusion two polymorphic sites in VDR gene and CYP2R1 gene were found to increase the sensitivity and accuracy of IL28B gene in predicting SVR rates for Peg-IFN and RBV therapy in CHC patients G4. The gene discussed is IFNL3; the disease is cryohydrocytosis.